Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedifastLTS:0K05 +35.23%58 FCF Margin % is 0.95% as of Jun. 2026, which is 91% below its 10-year median of 10.77. GuruFocus rates LTS:0K05 with a GF Score™ of 58/100 and a GF Value™ of $8.57 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 95 Personal Services companies, Medifast ranks worse than 61.05% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medifast's Free Cash Flow for the
three
months ended in Jun. 2026 was $0.7 Mil. Medifast's Revenue for the
three
months ended in Jun. 2026 was $76.4 Mil. Therefore, Medifast's FCF Margin % for the quarter that ended in Jun. 2026 was 0.95%.
The historical data trend for Medifast's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0K05 vs RGS, CLIK, EVTK: FCF Margin % Comparison
For the Personal Services subindustry, Medifast's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast FCF Margin % vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medifast's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (LTS:0K05) has a FCF Margin % of 0.95% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medifast and its competitors. This is 91% below median its historical median of 10.77. According to the industry distribution chart, Medifast ranks #58 out of 95 companies in the Personal Services industry, placing it in the top 61.1%.
Is Medifast's FCF Margin % too high?
Medifast's current FCF Margin % of 0.95% is 91% below median its 10-year median of 10.77. The Personal Services industry median FCF Margin % is 2.87. Medifast's value of 0.95% is 66.9% below this industry median. Based on the distribution chart, Medifast ranks #58 out of 95 companies in the Personal Services industry, which is below the industry midpoint. Overall, Medifast has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's FCF Margin % compare to RGS and CLIK?
According to the Personal Services industry distribution chart, Medifast ranks #58 out of 95 companies for FCF Margin %. This places Medifast in the lower half of its industry. The industry median FCF Margin % is 2.87. Medifast's value of 0.95% is 66.9% below this benchmark. While the company's 10-year median is 10.77 vs. the industry median of 2.87, Medifast has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Personal Services company?
The median FCF Margin % among Personal Services companies is 2.87, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medifast's current FCF Margin % of 0.95% is 66.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medifast and its competitors. For the Personal Services industry, the median FCF Margin % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current FCF Margin % is 0.95%, which is 91% below median its own 10-year median of 10.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (LTS:0K05) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.57, compared to a current price of $13.32 — trading 55.4% above its estimated fair value. The current FCF Margin % is 0.95%, which is 91% below median its 10-year median of 10.77 and 66.9% below the Personal Services industry median of 2.87. Medifast's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medifast (LTS:0K05), the current FCF Margin % is 0.95% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (LTS:0K05) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of $13.32 is trading 55.4% above its estimated GF Value™ of $8.57.
GuruFocus considers Medifast to be Significantly Overvalued.
Key valuation signals for LTS:0K05:
FCF Margin %: 0.95% (91% below median its 10-year median of 10.77)
GF Value™: $8.57 vs. price of $13.32 (55.4% above fair value)
Industry Position: 66.9% below the Personal Services median (#58 of 95)
No single metric tells the full story. See the LTS:0K05 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
58GF Score
Get the complete analysis for LTS:0K05
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0K05 has been successfully added to your 
